Details of the presentations for the Yselty program are as follows:
- Title: Long-Term Secondary Efficacy of Linzagolix for Heavy Menstrual Bleeding (HMB) Due to Uterine Fibroids (UF): 52-Week Results from Two Placebo-Controlled, Randomized, Phase 3 Trials
Format: Oral presentation followed by a Q&A session
Presenter: Hugh Taylor, M.D., Professor and Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine
Session Date & Time: Tuesday, June 29, 2021, at 4:15 PM CEST
- Title: Efficacy and Safety of Linzagolix for the Treatment of Severe Adenomyosis: Initial Results from a Pilot Study
Format: ePoster
Presenter: Olivier Donnez, M.D., Ph.D., Co-founder and Co-CEO of the Institut du sein et de Chirurgie Gynécologique d’Avignon
Session Date & Time: ePosters will be available on-demand through the ESHRE conference portal, on Saturday June 26 starting at 7:00 AM CEST
Details of the presentation for the nolasiban program are as follows:
- Title: The Effect of Nolasiban on Uterine Contractility at The Time of Embryo Transfer in in vitro Fertilisation Patients
Format: ePoster
Presenter: Connie Rees, M.D., investigator and physician specializing in obstetrics and gynecology, Catharina Hospital
Session Date & Time: ePosters will be available on-demand through the ESHRE conference portal, on Saturday June 26 starting at 7:00 AM CEST